The $44 million facility is part of Thermo Fisher's $650 million multi-year investment, announced last year, to help ensure flexible, scalable and reliable bioprocessing production capacity exists for critical materials used in developing new and existing biologics and vaccines, including for COVID-19
Healthium Medtech, a company focused on products used in surgical, post-surgical and chronic care has ramped up its play in the global healthcare industry. In an interview with Thomas C. Thottathil, Editor, Indian Pharma Post, Anish Bafna, CEO and MD, Healthium Medtech outlines his plans
Pharmapack trends are a key barometer of global device and packing opportunities in 2022
Through this new set-up, the company intends to make available, affordable high-quality medical diagnostic imaging equipment across Tier 2, 3, and 4 towns in India
It is one of the 15 medical device manufacturers approved under the government’s PLI scheme
Arzeda harnesses the power of computer-designed enzymes and applies the latest advances in digital biology
A staggering 65% of the TB cases in India are in the 15-45 age group
Srichakra receives European Food Safety approval for its food-grade recycled rPET
The focus should be on streamlining regulations, developing new molecules, increased industry academia collaboration and tapping the potential of traditional medicines
The agreement also had a permanent safeguard mechanism which can be resorted to in a situation of sudden surge in imports.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
